HomeOpen Access News

Open Access News

Accelerating industrial decarbonization through the Clean Industrial Deal Policy

Everest Group informs us about accelerating industrial decarbonization through the Clean Industrial Deal Policy.

Dogs can sniff out coronavirus with 96% accuracy

According to a new study, led by the University of Pennsylvania, specially trained detection dogs can sniff out positive COVID-19 samples with 96% accuracy.

Workplace technology design for a remote-first workforce

David Turner, Managing Director of MSC Digital, outlines the key features of technology design to ensure your organisation can support a complete or partial remote-first workforce.

Reducing outpatient waiting list backlog through innovation

Adapting their existing digital framework, SymlConnect address the severe outpatient waiting list backlog created by the impact of the COVID-19 pandemic, to enable secure patient-clinician remote communication.

PHE say 43,398 COVID patients sent into UK care homes

Public Health England (PHE) have revealed that 43,398 COVID-positive people were sent into care homes in the first ten months of 2020.

Are you protected against work from home fraud?

Working from home is now the norm for so many people, but with one in ten employees still wanting a remote lifestyle for the foreseeable future, what does that mean for employers and what exactly are the risks?.

Rapid COVID-19 test kit receives scientific seal of approval

Researchers from Simon Fraser University have approved a faster, cheaper COVID-19 test kit that could expand more widespread rapid testing.

New study finds high levels of mercury in Pacific Ocean

Scientists say that levels of mercury in the Pacific Ocean are even higher than some places directly contaminated by the toxic chemical.

UK approves use of single-dose Johnson & Johnson COVID vaccine

The UK today (28 May) approves use of the single-dose Johnson & Johnson vaccine that provides enough protection against the virus in one injection.

IBS patients’ experienced improved symptoms during COVID-19 lockdown

According to new research, patients with irritable bowel syndrome (IBS) unexpectedly experienced improved symptoms during COVID-19 lockdown.

Fostering future net-zero with sustainable food manufacturing

James Sopwith, group strategic account director at adi Group, discusses engineering’s part in supporting a smarter, healthier and altogether more sustainable food manufacturing operation.

Scientists link AstraZeneca vaccine to arterial blood clots

Over the last three months, scientists have been tracing rare instances of blood clots in veins in connection to the AstraZeneca COVID vaccine - now, they have the first evidence of arterial blood clots, which can cause stroke.

What are the side effects of the Johnson & Johnson vaccine?

Here, we discuss some of the common misconceptions about side effects of the Johnson & Johnson COVID vaccine.

To scale the circular economy, we must unite and work towards common policy goals

Miranda Schnitger, Government Lead at the Ellen MacArthur Foundation, discusses the importance of the Universal circular economy policy goals to deliver the circular economy, particularly as we enter the year of COP26.

Public safety and smart cities: How assistive AI will help

Jack Williams, Strategic Product Manager – AI & Analytics, Hexagon’s Safety & Infrastructure division, explores how assistive artificial intelligence (AI) will help public safety and smart cities of the future.

US pushes for investigation into origins of COVID-19

President Biden asked US intelligence agencies to begin investigating the origins of COVID-19 yesterday (26 May) - the international WHO team were unable to access all available data in their March trip to Wuhan.

Ground-breaking technology: Next generation sequencing

Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, provides a portrait of a ground-breaking technology, next-generation sequencing, starting with a brief snapshot.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders